Skip to content
AI IntelligenceApr 12, 2026Secondary Market
Article

PFE

Bank of America lowers its price target on Pfizer to $26 from $27. The revision comes amid a reassessment of the product portfolio and pipeline. Analysts remain cautiously optimistic about long-term growth prospects.

Data Cube AI EditorialSource: Yahoo Finance
01

Source Brief

Bank of America lowers its price target on Pfizer to $26 from $27. The revision comes amid a reassessment of the product portfolio and pipeline. Analysts remain cautiously optimistic about long-term growth prospects.